Trial
NCT03859869
A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AbbVie
Collaborators
—
Condition
Exocrine Pancreatic Insufficiency (EPI)
Intervention
Pancrelipase
Why stopped
Business Considerations (difficulty with enrollment)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-05